|
|
Article: CONTINUATION: NHS refuses to fund the pill that offers relief to millions of hay fever sufferers ; THE CURE AND THE CATCH
- Article from:
- The Independent (London, England)
- Article date:
- June 12, 2007
CopyrightCopyright 2007 The Independent - London. Provided by ProQuest LLC. (Hide copyright information)
|
fever season at its peak, millions of people with an allergy to
grass pollen are sneezing, snuffling and rubbing itchy eyes. Hay
fever affects about 20 per cent of the UK population - more than 10
million people - of whom up to one million are so badly affected it
interferes with their lives.
The new treatment, Grazax, is the first oral vaccine for hay
fever developed to tackle the underlying condition rather than the
symptoms. Manufactured by a Danish company, and licensed in January,
it contains small amounts of Timothy grass and is designed to
"recondition" the immune system's response to pollen in people who
do not respond to normal treatment.
According to a study released yesterday, ...